Renal Research Institute Fellow Receives International Society of Nephrology Award
March 25 2015 - 7:00AM
Business Wire
Dr. Viviane Calice-Silva awarded for poster
submission focused on cardiovascular disease in renal
patients
Renal Research Institute (RRI), a division of Fresenius Medical
Care North America, announced today that judges at the
International Society of Nephrology’s (ISN) World Congress of
Nephrology (WCN) in Cape Town, South Africa, have awarded RRI
Research Fellow Dr. Viviane Calice-Silva the ISN’s Fellowship
Poster 3rd prize.
Dr. Calice-Silva’s submission is entitled Multinational study
of the relationship between fluid status and left ventricular
structure and function in chronic hemodialysis patients. It
presents the relationship between indicators of cardiac structure
and function, determined by renal patients‘echocardiography and its
relationship with fluid status assessed by the Body Composition
Monitor (BCM), Fresenius Medical Care Germany. Renal patients who
were included in this study are from 11 countries. While some of
Dr. Calice-Silva’s results concur with observations in the general
population, they have never previously been shown for a
multinational population of hemodialysis patients.
“The ISN Fellowship prize was a great surprise and a very nice
recognition,” said Dr. Calice-Silva. “My fellowship at RRI has been
of great inspiration, allowing me to meet people from different
fields and regions of the world who work together with one unique
aim, to improve patient care and outcomes. It has been a period of
personal and professional learning that certainly will enable me to
provide even better care for my patients in the future.”
Dr. Calice-Silva, a nephrologist who practices in Brazil, joined
RRI as a Research Fellow in June 2014. Nephrologists from
approximately 30 countries have served as RRI fellows since the
organization’s fellowship program was created in 1997.
“She’s doing outstanding work with us,” said Dr. Peter Kotanko,
research director at RRI. “The award is really important. It is a
great testament to how RRI interacts with academic institutions
abroad. These kinds of collaborations with academic institutions
give rise to such really great research, which is internationally
recognized.”
Dr. Calice-Silva’s primary work at RRI involves analyzing
congestive heart failure, arrhythmia and sudden cardiac death data
from the international Monitoring Dialysis Outcomes (MONDO) data
base, to identify predictors of death due to these conditions. Her
work at RRI will continue through the end of April 2015.
About Renal Research Institute
The Renal Research Institute (RRI), a division of Fresenius
Medical Care North America, conducts research in collaboration with
our academic and teaching hospital partners in the US and abroad,
aimed at improving the health outcomes and quality of life of
patients with renal disease. RRI operates dialysis clinics in six
states, primarily under the Avantus Renal Therapy brand. Patients
treated at an Avantus Renal Therapy clinic benefit most directly
and immediately from the latest insights gained at RRI into
improving renal care. RRI puts its research findings and innovative
technologies to work for our patients while setting a higher
standard for quality of care.
About Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the premier
health care company focused on delivering the highest quality care
to people with renal and other chronic conditions. Through its
industry-leading network of dialysis facilities, outpatient cardiac
and vascular labs and urgent care centers, as well as the country’s
largest practice of hospitalist and post-acute providers, FMCNA
provides coordinated health care services at pivotal care points
for hundreds of thousands of chronically ill customers throughout
the continent. As the world’s only vertically integrated renal
company, it offers specialty pharmacy and laboratory services, and
manufactures and distributes the most comprehensive line of
dialysis equipment, disposable products and renal pharmaceuticals.
(www.fmcna.com)
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20150325005079/en/
Media Contact:Fresenius Medical CareJon Stone, 781-699-9704 (o)
/ 781-392-4680 (cell)jonathan.d.stone@fmc-na.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Sep 2023 to Sep 2024